Freedom for Farmers Act of 2025This bill abolishes the Agency for Toxic Substances and Disease Registry. Currently, this agency, which is part of the Department of Health and Human Services (HHS), investigates and responds to environmental exposures to hazardous substances in communities. The bill requires HHS to transfer authority regarding certain national disease and toxic exposure registries to another appropriate HHS entity.
The abolishment of the ATSDR is expected to have significant implications for how toxic substances and related health concerns are monitored and addressed at the federal level. By transferring the authority to HHS, the bill aims to centralize functions, which proponents argue will enhance efficiency. However, critics express concern that this transition could lead to diminished oversight and reduced focus on the unique health risks posed by toxic substances, adversely impacting environmental health initiatives that the ATSDR currently oversees. The national registry of individuals exposed to toxic substances and serious illnesses is suggested to be at risk, potentially leading to gaps in data critical for public health policymaking.
House Bill 91 seeks to abolish the Agency for Toxic Substances and Disease Registry (ATSDR), which is responsible for evaluating and reporting on the impact of toxic substances on public health and maintaining national registries for serious diseases and exposures. The bill proposes that all functions of the ATSDR would terminate one year after enactment, transferring its critical responsibilities to the Department of Health and Human Services (HHS). This move is positioned as a means to streamline governmental functions, potentially consolidating resources and authority within existing federal health structures.
The proposal has generated debate, as various stakeholders weigh the benefits of administrative efficiency against potential risks to public health monitoring and response. Supporters contend that the elimination of the ATSDR is a logical step to consolidate functions and improve the effectiveness of federal health agencies. They argue that HHS is better positioned to manage these responsibilities. Conversely, opponents of the bill fear that the loss of a dedicated agency focused on toxic substance exposure could result in less rigorous public health surveillance and a weaker response capability regarding environmental health crises.